Home
GSC Advanced Research and Reviews
Peer-reviewed | Multidisciplinary Journal | Impact factor 8.3 | ISSN: 2582-4597 | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Microbial dysbiosis and associated human diseases

Breadcrumb

  • Home
  • Microbial Dysbiosis and Associated Human Diseases
  • Microbial dysbiosis and associated human diseases

Mehnaz Khan 1, Sharique Ahmad 1, * and Pushpendra D. Pratap 2

1 Department of Pathology, Era's Lucknow Medical College and Hospital, Era University, Lucknow, Uttar Pradesh, India.
2 Department Biochemistry, Era's Lucknow Medical College and Hospital, Era University, Lucknow, Uttar Pradesh, India.
 
Research Article
GSC Advanced Research and Reviews, 2024, 20(02), 021–035.
Article DOI: 10.30574/gscarr.2024.20.2.0297
DOI url: https://doi.org/10.30574/gscarr.2024.20.2.0297
Received on 16 June 2024; revised on 05 August 2024; accepted on 07 August 2024
 
Dysbiosis, a disturbance in the normal balance of microbial communities within the body, particularly the gut, is linked to various diseases. The human microbiota is essential for health, aiding digestion, synthesizing vitamins, modulating the immune system, and protecting against pathogens. Dysbiosis can result from factors like antibiotic use, dietary changes, infections, and chronic diseases, potentially leading to or worsening multiple health conditions.
Gastrointestinal diseases are prominently associated with dysbiosis, Conditions such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and colorectal cancer have shown connections to gut microbiota alterations. In IBD, for instance, patients often display reduced microbial diversity and an overgrowth of harmful bacteria, contributing to inflammation and tissue damage. In IBS, dysbiosis may affect gut motility, sensitivity, and immune responses, causing symptoms like pain, bloating, and altered bowel habits.
Beyond gastrointestinal issues, dysbiosis is also implicated in metabolic disorders like obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD). The gut microbiota influences energy extraction from food, fat storage, and insulin sensitivity. Dysbiosis can promote inflammation and alter metabolic pathways, thus contributing to these conditions. Certain bacterial metabolites, such as short-chain fatty acids (SCFAs), are crucial in regulating host metabolism, and imbalances in their production can impact metabolic health.
Moreover, the gut-brain axis, a communication system between the gut microbiota and the brain, demonstrates the impact of dysbiosis on mental health and neurological disorders. Dysbiosis has been linked to depression, anxiety, and neurodegenerative diseases like Parkinson's and Alzheimer's. Microbial metabolites, including neurotransmitters and inflammatory molecules, can affect brain function and behaviour, underscoring the importance of gut health for mental well-being.
The factors contributing to dysbiosis are varied and complex. Antibiotics, although vital for treating infections, can kill beneficial bacteria indiscriminately, leading to reduced diversity and imbalance. Diet significantly influences the microbiota; high-fat, high-sugar diets can foster the growth of harmful bacteria, whereas fibre-rich diets support beneficial microbes. Gastrointestinal infections can disrupt the microbiota and allow pathogen overgrowth. Chronic diseases, such as autoimmune disorders and cancers, can alter microbial communities directly through disease mechanisms or indirectly through treatments like chemotherapy.
In summary, dysbiosis is a multifaceted condition influenced by numerous factors and linked to various diseases beyond the gastrointestinal tract. Understanding the complex relationships between the microbiota and host health is essential for developing targeted therapies to restore microbial balance and treat dysbiosis-related diseases.
 
Dysbiosis; Gut microbiota; Gut-brain axis. Microbial diversity; Metabolic health
 
https://gscarr.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCARR-2024-…

Preview Article PDF

Mehnaz Khan, Sharique Ahmad and Pushpendra D. Pratap. Microbial dysbiosis and associated human diseases. GSC Advanced Research and Reviews, 2024, 20(2), 021-035. Article DOI: https://doi.org/10.30574/gscarr.2024.20.2.0297

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 GSC Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution